Template:SUIT-001: Difference between revisions

From Bioblast
No edit summary
No edit summary
Line 17: Line 17:
| [[N]]
| [[N]]
| CI
| CI
| PM<sub>''P''</sub> or PM_P: N-OXPHOS capacity, N<sub>''P''</sub>
| {{Template:SUIT N}} {{Template:SUIT OXPHOS}}
 
{{Template:SUIT N}} {{Template:SUIT OXPHOS}}


|-
|-
Line 26: Line 24:
| [[N]]
| [[N]]
| CI
| CI
| PMc<sub>''P''</sub> or PMc_P: Cytochrome c test for quality control
| {{Template:SUIT N}} {{Template:SUIT OXPHOS}} {{Template:SUIT c}}
 
{{Template:SUIT N}} {{Template:SUIT OXPHOS}} {{Template:SUIT c}}


|-
|-
Line 35: Line 31:
| [[N]]
| [[N]]
| CI
| CI
| PM<sub>''E''</sub> or PM_E: N-ET capacity, N<sub>''E''</sub>
| {{Template:SUIT N}} {{Template:SUIT U*}}
 
{{Template:SUIT N}} {{Template:SUIT U*}}


|-
|-
Line 44: Line 38:
| [[N]]
| [[N]]
| CI
| CI
| PGM<sub>''E''</sub> or PGM_E: N-ET capacity, N<sub>''E''</sub>
| {{Template:SUIT N}} {{Template:SUIT ET}}
 
{{Template:SUIT N}} {{Template:SUIT ET}}


|-
|-
Line 53: Line 45:
| [[NS]]
| [[NS]]
| CI&II
| CI&II
| GMS<sub>''E''</sub> or GMS_E: NS-OXPHOS capacity, NS<sub>''E''</sub>
| {{Template:SUIT N}} & {{Template:SUIT S}} {{Template:SUIT NS}} {{Template:SUIT ET}}
 
{{Template:SUIT N}} & {{Template:SUIT S}} {{Template:SUIT NS}} {{Template:SUIT ET}}


|-
|-
Line 62: Line 52:
| [[FNS]]
| [[FNS]]
| FAO&CI&II
| FAO&CI&II
| OctGMS<sub>''P''</sub> or GMS_P: NS-OXPHOS capacity, NS<sub>''P''</sub>
| {{Template:SUIT FNS}} {{Template:SUIT ET}}
 
{{Template:SUIT FNS}} {{Template:SUIT ET}}


|-
|-
Line 71: Line 59:
| [[S]]
| [[S]]
| CII
| CII
| S<sub>''E''</sub> or S_E: S-ET capacity
| {{Template:SUIT Rot}} {{Template:SUIT ET}}
 
{{Template:SUIT Rot}} {{Template:SUIT ET}}


|-
|-
Line 80: Line 66:
| [[SGp]]
| [[SGp]]
| CII&GpDH
| CII&GpDH
| SGp<sub>''E''</sub> or SGp_E: SGp-ET capacity
| {{Template:SUIT SGp}} {{Template:SUIT ET}}
 
{{Template:SUIT SGp}} {{Template:SUIT ET}}


|-
|-
Line 89: Line 73:
|  
|  
|   
|   
| ROX: residual oxygen consumption
| {{Template:SUIT Ama}}
 
{{Template:SUIT Ama}}


|}
|}


{{Template:SUIT CIV}}
{{Template:SUIT CIV}}

Revision as of 17:07, 11 January 2019

SUIT-001

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1PM PML N CI PML or PM_L: Pyruvate & Malate, N-LEAK respiration, NL

NADH-linked substrates (type N-pathway to Q). Template:SUIT L n

2D PMP N CI NADH-linked substrates (type N-pathway to Q). OXPHOS capacity P (with saturating [ADP]), active OXPHOS state.
2c PMcP N CI NADH-linked substrates (type N-pathway to Q). OXPHOS capacity P (with saturating [ADP]), active OXPHOS state. Addition of cytochrome c yields a test for integrity of the mtOM (cytochrome c control efficiency). Stimulation by added cytochrome c would indicate an injury of the mtOM and limitation of respiration in the preceding state without added c due to loss of cytochrome c. Typically, cytochrome c is added immediately after the earliest ADP-activation step (OXPHOS capacity P with saturating [ADP]).
3U PME N CI NADH-linked substrates (type N-pathway to Q). Uncoupler titration (avoiding inhibition by high uncoupler concentrations) to obtain electron transfer (ET) capacity E (noncoupled ET-state). Test for limitation of OXPHOS capacity P by the phosphorylation system (ANT, ATP synthase, phosphate transporter) relative to ET capacity E in mt-preparations: E-P control efficiency and E-L coupling efficiency. In living cells: E-R control efficiency and E-L coupling efficiency.
4G PGM(E) N CI NADH-linked substrates (type N-pathway to Q). Noncoupled electron transfer state, ET state, with ET capacity E.
5S PGMSE NS CI&II NADH-linked substrates (type N-pathway to Q). & Succinate, S ( type S-pathway to Q). Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function. Noncoupled electron transfer state, ET state, with ET capacity E.
6Oct OctPGMSE FNS FAO&CI&II Respiratory stimulation by simultaneous action of the F-pathway, N-pathway, and S-pathway, with convergent electron flow in the FNS-pathway for reconstitution of TCA cycle function and additive or inhibitory effect of F. Noncoupled electron transfer state, ET state, with ET capacity E.
7Rot SE S CII Succinate pathway control state (S-pathway) after inhibiting CI with rotenone, which also inhibits the F-pathway. Noncoupled electron transfer state, ET state, with ET capacity E.
8Gp SGp(E) SGp CII&GpDH Respiratory stimulation by action of succinate and glycerophosphate, Gp, with convergent electron flow in the SGp-pathway (CII&GpDH-linked pathway to the Q-junction). Noncoupled electron transfer state, ET state, with ET capacity E.
9Ama ROX Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).
Step Respiratory state Pathway control ET-Complex Comment
## AsTm AsTmE CIV CIV
## Azd CHB
Cookies help us deliver our services. By using our services, you agree to our use of cookies.